Cleveland BioLabs (CBLI +5.8%) trades up after saying Russian investment firm Rusnano will spend up to $26M over the next four years to help fund a new company unit that will develop a portfolio of new preclinical drug candidates.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs